Carregant...
Costs of multidrug-resistant TB treatment in Finland and Estonia affected by the 2019 WHO guidelines
BACKGROUND: Multidrug-resistant TB (MDR-TB) is a growing problem in the effort to end the global TB epidemic. In 2019, the WHO adopted a new standardised regiment for MDR-TB, consisting of only oral medications. METHODS: We estimated the impact of the new guidelines on the costs of TB treatment in E...
Guardat en:
| Publicat a: | Int J Tuberc Lung Dis |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
International Union Against Tuberculosis and Lung Disease
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8259121/ https://ncbi.nlm.nih.gov/pubmed/34183100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5588/ijtld.20.0892 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|